Fractyl Health, Inc. Common Stock (GUTS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $13.16M
Last updated: Nov 17, 2026 at 4:40 PM ET
Fractyl Health, Inc. Common Stock (GUTS) Statistics
Fractyl Health, Inc. Common Stock (GUTS) has a market cap of $13.16M and an enterprise value of $11.29M. Its share count is up 145.93% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 14.20% below the market cap, as cash exceeds debt.
| Market Cap | $13.16M |
|---|---|
| Enterprise Value | $11.29M |
| Latest price (Nov 17, 2026) | $0.97 |
Key Dates
| Last Earnings Date | Nov 12, 2026 |
|---|---|
| Fiscal Year End | September |
Price Statistics
The stock is down 93.62% over 52 weeks and trades 73.06% below its 50-day average.
| Beta (1Y) | 2.47 |
|---|---|
| 52-Week Change | -93.62% |
| 1-Month Change | -30.04% |
| 3-Month Change | -88.27% |
| 6-Month Change | -90.15% |
| Total Return (1Y) | -93.62% |
| Max Drawdown (1Y) | -97.15% |
| Max Drawdown (3Y) | -99.47% |
| Sharpe Ratio (1Y) | -1.61 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $3.60 |
| 200-Day Average | $6.76 |
| 52-Week Range | $0.80 to $29.34 |
| RSI (14 Days) | 26.6 |
| Average Volume (20 Days) | 416.16K |
Financial Position
Current assets cover 1.98x current liabilities.
| Current Ratio | 1.98x |
|---|---|
| Quick Ratio | 1.98x |
Returns and Efficiency
Return on invested capital is -356.74% over the last 12 months, against a 5-year average of -56.93%.
| Return on Assets (ROA) | -112.55% |
|---|---|
| Return on Invested Capital (ROIC) | -356.74% |
| Return on Capital Employed (ROCE) | -152.73% |
| ROA (5Y Average) | -78.96% |
| ROIC (5Y Average) | -56.93% |
Scores
GUTS has an Altman Z-Score of -15.77, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -15.77 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Operating Income | -$81.85M |
| Pretax Income | -$74.20M |
| Net Income | -$74.20M |
| EBITDA | -$73.08M |
| EBIT | -$74.20M |
| Reported EPS (TTM) | -$1.52 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $31.52M |
|---|---|
| Total Debt | $29.65M |
| Net Cash | $1.87M |
| Net Cash Per Share | $0.14 |
| Working Capital | $16.99M |
| Shareholder Equity | -$13.22M |
| Total Assets | $65.92M |
| Total Liabilities | $79.14M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $3.00K of capital spending, operating cash flow left -$75.42M of free cash flow.
| Operating Cash Flow | -$75.42M |
|---|---|
| Capital Expenditures | $3.00K |
| Free Cash Flow | -$75.42M |
| FCF Per Share | -$5.69 |
| Depreciation and Amortization | $1.56M |
Trailing 12 months through Sep 30, 2026.
Stock Splits
The last split was a 1-for-12 reverse split on Oct 5, 2026.
| Last Split Date | Oct 5, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:12 |
Peer Position
Against 5 similar companies, GUTS has the 4th highest ROIC.
ROICPeer median -150.11%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -32.90%
| ROIC | -356.74% vs -150.11% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -100.00% vs -32.90% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About GUTS
What is GUTS's market cap?
Fractyl Health, Inc. Common Stock has a market cap of $13.16M. Its enterprise value, which adds debt and subtracts cash, is $11.29M.
How many shares of GUTS are outstanding?
Fractyl Health, Inc. Common Stock has 13.25M shares outstanding. The count is up 145.93% from a year earlier.
Does GUTS pay a dividend?
No. Fractyl Health, Inc. Common Stock does not pay a dividend.
How much debt does GUTS have?
Fractyl Health, Inc. Common Stock has $29.65M of total debt and $31.52M of cash and equivalents, a net cash position of $1.87M.
GUTS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors